Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Akin

Showing results (101-110 of 795) with videos related to

Pageof 80
Sort By:
Ebiomedicine|August 12, 2023
Variable Brugada syndrome phenotype severity in a dish: dreams meet realityIbrahim El-Battrawy, Nazha Hamdani, Xiaobo Zhou, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 30, 2021
α1-adrenoceptors and takotsubo syndrome: pathophysiologic connotations-Authors' replyMengying Huang, Ibrahim El-Battrawy, Xiaobo Zhou, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 27, 2023
[Asymptomatic channelopathies : Risk stratification and primary prophylaxis]Assem Aweimer, Andreas Mügge, Ibrahim Akin, et al.
European Journal of Internal Medicine|April 16, 2026
Heart failure and COPD - Disentangling undertreatment from the impact of severe comorbiditiesHenning Johann Steffen, Michael Behnes, Ibrahim Akin, et al.
International Journal of Cardiology. Heart & Vasculature|April 2, 2025
The use of sacubitril/valsartan in different forms of heart failureMohammad Abumayyaleh, Nazha Hamdani, Ibrahim El-Battrawy, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 2, 2014
Triple antiplatelet therapy after PCI--should or could it be done?Banu Sahin Yildiz, Mustafa Yildiz, Ebuzer Aydin, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 2, 2014
Stent thrombosis--mythy and factsMustafa Yildiz, Banu Sahin Yildiz, Ebuzer Aydin, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 16, 2015
New Oral Anticoagulation after Heart Valve ReplacementIbrahim El-Battrawy, Stefan Baumann, Aydin Huseynov, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 4, 2019
'Mature' resting membrane potentials in hiPSC-CMs: fact or artefact?-Authors' replyIbrahim El-Battrawy, Lukas Cyganek, Xiaobo Zhou, et al.
International Journal of Cardiology. Heart & Vasculature|July 21, 2025
Intravenous iron in heart failure: still no prognostic impact, but questions remainIbrahim El-Battrawy, Nazha Hamdani, Mohammad Abumayyaleh, et al.
Pageof 80

Showing results (101-110 of 795) with videos related to

Sort By:
Pageof 80
Ebiomedicine|August 12, 2023
Variable Brugada syndrome phenotype severity in a dish: dreams meet realityIbrahim El-Battrawy, Nazha Hamdani, Xiaobo Zhou, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 30, 2021
α1-adrenoceptors and takotsubo syndrome: pathophysiologic connotations-Authors' replyMengying Huang, Ibrahim El-Battrawy, Xiaobo Zhou, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 27, 2023
[Asymptomatic channelopathies : Risk stratification and primary prophylaxis]Assem Aweimer, Andreas Mügge, Ibrahim Akin, et al.
European Journal of Internal Medicine|April 16, 2026
Heart failure and COPD - Disentangling undertreatment from the impact of severe comorbiditiesHenning Johann Steffen, Michael Behnes, Ibrahim Akin, et al.
International Journal of Cardiology. Heart & Vasculature|April 2, 2025
The use of sacubitril/valsartan in different forms of heart failureMohammad Abumayyaleh, Nazha Hamdani, Ibrahim El-Battrawy, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 2, 2014
Triple antiplatelet therapy after PCI--should or could it be done?Banu Sahin Yildiz, Mustafa Yildiz, Ebuzer Aydin, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 2, 2014
Stent thrombosis--mythy and factsMustafa Yildiz, Banu Sahin Yildiz, Ebuzer Aydin, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 16, 2015
New Oral Anticoagulation after Heart Valve ReplacementIbrahim El-Battrawy, Stefan Baumann, Aydin Huseynov, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 4, 2019
'Mature' resting membrane potentials in hiPSC-CMs: fact or artefact?-Authors' replyIbrahim El-Battrawy, Lukas Cyganek, Xiaobo Zhou, et al.
International Journal of Cardiology. Heart & Vasculature|July 21, 2025
Intravenous iron in heart failure: still no prognostic impact, but questions remainIbrahim El-Battrawy, Nazha Hamdani, Mohammad Abumayyaleh, et al.
Pageof 80